- Home
- TXG vs NAGE Comparison
TXG vs NAGE Comparison
Compare TXG & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- NAGE
- Stock Information
- Founded
- TXG 2012
- NAGE 1999
- Country
- TXG United States
- NAGE United States
- Employees
- TXG N/A
- NAGE N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- TXG Industrials
- NAGE Health Care
- Exchange
- TXG Nasdaq
- NAGE Nasdaq
- Market Cap
- TXG 1.1B
- NAGE 861.0M
- IPO Year
- TXG 2019
- NAGE N/A
- Fundamental
- Price
- TXG $10.65
- NAGE $13.52
- Analyst Decision
- TXG Buy
- NAGE Strong Buy
- Analyst Count
- TXG 15
- NAGE 3
- Target Price
- TXG $15.81
- NAGE $16.67
- AVG Volume (30 Days)
- TXG 3.7M
- NAGE 964.6K
- Earning Date
- TXG 08-07-2025
- NAGE 08-06-2025
- Dividend Yield
- TXG N/A
- NAGE N/A
- EPS Growth
- TXG N/A
- NAGE N/A
- EPS
- TXG N/A
- NAGE 0.18
- Revenue
- TXG $624,662,000.00
- NAGE $107,925,000.00
- Revenue This Year
- TXG N/A
- NAGE $26.21
- Revenue Next Year
- TXG $5.70
- NAGE $20.91
- P/E Ratio
- TXG N/A
- NAGE $75.15
- Revenue Growth
- TXG N/A
- NAGE 29.77
- 52 Week Low
- TXG $6.78
- NAGE $2.31
- 52 Week High
- TXG $24.76
- NAGE $13.84
- Technical
- Relative Strength Index (RSI)
- TXG 66.58
- NAGE N/A
- Support Level
- TXG $8.95
- NAGE N/A
- Resistance Level
- TXG $9.79
- NAGE N/A
- Average True Range (ATR)
- TXG 0.54
- NAGE 0.00
- MACD
- TXG 0.15
- NAGE 0.00
- Stochastic Oscillator
- TXG 96.64
- NAGE 0.00
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.